Amifostine Followed by High Dose Chemotherapy in Treating Patients With Hematologic Cancer or Solid Tumors

Clinical trial NCT00003269 · COMPLETED

Trial details

NCT number: NCT00003269
Sponsor: Scripps Health
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Breast Cancer Drug/Agent Toxicity by Tissue/Organ Lung Cancer Lymphoma Ovarian Cancer Unspecified Adult Solid Tumor, Protocol Specific

Start date: 1998-02-01
Primary completion: 2001-01-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.